Wait a second!
More handpicked essays just for you.
More handpicked essays just for you.
Adult-onset mitochondrial disease
Don’t take our word for it - see why 10 million students trust us with their essay needs.
Recommended: Adult-onset mitochondrial disease
Some symptoms of mitochondrial diseases are subtle while others are lifelong and easily noticable. Mitochondrial disease can either be adult-onset or child-onset; usually childhood mitochondrial disease is more astringent “and includes progressive neurological, cardiac, and liver dysfunction.” An expansive array of symptoms may be apparent in childhood mitochondrial disease, “including lethargy, hypotonia, failure to thrive, seizures, cardiomyopathy, deafness, blindness, movement disorder, and lactic acidosis.” On the other hand, most patients with mitochondrial disease do not display very discernible symptoms. Most recognizable symptoms can usually be attributed to other causes; however, further analysis may lead to mitochondrial mutations being the definitive cause, especially these symptoms within the following systems. Mitochondrial diseases of the central nervous system or the peripheral nervous system usually show the stereotypical childhood symptoms, such as “developmental delay or regression, seizures, and movement disorders.” In adult-onset mitochondrial disease, symptoms would instead involve stroke or stroke-like episodes. Symptomatic or nonsymptomatic peripheral neuropathy may be revealed upon “phys¬ical examination or through nerve conduction studies.” Due to mitochondrial maladies within the auditory system, sensorineural deafness due to cochlear dysfunction and dysfunction of mitochondria within cranial nerve VIII may occur. Because ocular muscles contain the “highest density of mitochondria per cell of any type of muscle and thus use large amounts of adenosine triphosphate, mitochondrial disease within the ocular system are rather abundant. Symptoms of these ocular syndromes include progressive external ophthalmop...
... middle of paper ...
...G, Yolanda Lillquist, MD, FRCPC. "Mitochondrial Disease Clinical Manifestations: An Overview." British Columbia Medical Journal 53.4 (2011): 183-87. BC Medical Journal. Web. 18 Apr. 2014. .
Sirrs, Sandra, MD, FRCPC, Margaret O'Riley, RN, MA, Lorne Clark, MDCM, FRCPC,
FCCMG, and Andre Mattman, MD, FRCPC. "Primer on Mitochondrial Disease: Biochemistry, Genetics, and Epidemiology." British Columbia Medical Journal 53.4 (2011): 172-76. BC Medical Journal. Web. 18 Apr. 2014. .
"What Is Mitochondrial Disease?" What Is Mitochondrial Disease. United Mitochondrial
Disease Foundation, n.d. Web. 19 Apr. 2014. .
1. James suffers from a condition called Duchenne muscular dystrophy. Explain the full meaning of this name.
...hromosome and the disease/disorder is passed down in an X linked recessive fashion. Symptoms include muscle weakening and wasting, and pain in the lower body. Mostly only the lower body’s muscles are affected causing the child to have to be confined to a wheelchair. The best way to diagnose Duchenne Muscular Dystrophy is by doing a muscle biopsy to test for abnormal dystrophin levels. There is no treatment for the disease/disorder itself, but only for the symptoms of it. The average age of death in males with Duchenne Muscular Dystrophy is the late thirty’s. Most deaths are caused by breathing complications or heart problems like cardiomyopathy. Duchenne Muscular Dystrophy on average affects one in thirty five hundred male births worldwide. Overall, Duchenne Muscular Dystrophy is very hard to live with and affects many boys around the world.
Olivopontocerebellar atrophy (OPCA) was first described in 1900 by Dejerine and Thomas. OPCA is a group of dominant inheritance and sporadic neurological disorders characterized by a chronic, progressive, cerebellar ataxia that begins in middle age. The cerebellum and its connections are the primary sites of the disease in chronic progressive disorders that often occur in familial or hereditary patterns. Postmortem studies indicate an atrophy of the cerebellum, pons, and inferior olives. This neuropathological neuronal cell loss permits classification of OPCA as a non-Alzheimer’s neurodegenerative illness.
Faries, D. E., Houston, J. P., Sulcs, E. N., & Swindle, R. W. (2012). A cross-validation of the provisional diagnostic instrument (PDI-4). BioMed Central, 13(1), 104. doi:10.1186/1471-2296-13-104
Chronic Wasting Disease is a highly transmissible, deadly neurodegenerative disease that affects cervids in North America (Belay et al., 2004; Saunders et al., 2012). There are only four types of cervid that are known to get this disease which include elk, mule deer, white-tailed deer, and moose (Chronic Wasting Disease Alliance). It has been classified has a transmissible spongiform encephalopathy (TSE), otherwise known as a prion disease (Belay et al., 2004). A prion is an irregular, pathogenic agent that causes abnormal folding of specific proteins called prion proteins. These proteins are mostly located in the brain (Chronic Wasting Disease Alliance). The abnormal folding of this protein causes neurodegenerative diseases in a variety of species including humans, sheep, cattle, and deer (Abrams et al., 2011).
Addison’s disease is a disorder of the endocrine system. It is a hormonal disorder that can strike anyone, any gender at any age. Addison’s disease has also been called Adrenal Insufficiency (hypocortisolism) because the root of the disease is in the adrenal gland not producing enough of the hormone cortisol, or sometimes not enough of the hormone aldosterone to satisfy the body’s needs.
On admission, a complete physical assessment was performed along with a blood and metabolic panel. The assessment revealed many positive and negative findings. J.P. was positive for dyspnea and a productive cough. She also was positive for dysuria and hematuria, but negative for flank pain. After close examination of her integumentary and musculoskeletal system, the examiner discovered a shiny firm shin on the right lower extremity with +2 edema complemented by severe pain. A set of baseline vitals were also performed revealing a blood pressure of 124/80, pulse of 87 beats per minute, oxygen saturation of 99%, temperature of 97.3 degrees Fahrenheit, and respiration of 12 breaths per minute. The blood and metabolic panel exposed several abnormal labs. A red blood cell count of 3.99, white blood cell count of 22.5, hemoglobin of 10.9, hematocrit of 33.7%, sodium level of 13, potassium level of 3.1, carbon dioxide level of 10, creatinine level of 3.24, glucose level of 200, and a BUN level of 33 were the abnormal labs.
Myotonic dystrophy, type 1, is a genetic disorder which is linked to chromosome number 19 in humans. The dystrophia myotonica protein kinase gene is located on the q arm of the chromosome at the locus of 13.32. It is an autosomal dominant disorder, which means that the individuals that are affected by this disorder and contain at least one dominant allele for the dystrophia myotonica protein kinase gene. The disorder is caused by a series of repeats of a trinucleotide region that is expanded beyond the normal levels (Musova et al., 2009). The trinucleotide region is a series of repeats of CTG in the untranslated region of the dystrophia myotonica protein kinase gene. The severity of the disorder is associated with the number of repeats the individual has within the gene. Normal individuals tend to have between 5 and 37 repeats while an individual with a very mild myotonic dystrophy may have 50 to 150 repeats, and if the disorder is discovered at the time of birth the individual will have over 2,000 repeats of the trinucleotide region (Musova et al., 2009). Myotonic dystrophy, type 1, affects multiple organ systems of the body and is relatively slow to progress. Myotonic dystrophy, type 1, is categorized by alterations of the beating pattern of the heart, faulty dystrophin proteins, clouding of the lens of the eye, decreased functionality of the gonads, balding, and myotonia (Musova et al., 2009). Myotonia is described as the slow relaxation of any muscle type, which will cause the individual to use extended effort to simply relax the muscles after they have been contracted. Muscular dystrophy causes an individual to experience muscular deg...
Parkinson disease (PD), also referred to as Parkinson’s disease and paralysis agitans, is a progressive neurodegenerative disease that is the third most common neurologic disorder of older adults. It is a debilitating disease affecting motor ability and is characterized by four cardinal symptoms: tremor rigidity, bradykinesia or kinesis (slow movement/no movement), and postural instability. Most people have primary, or idiopathic, disease. A few patients have secondary parkinsonian symptoms from conditions such as brain tumors and certain anti-psychotic drugs.
5. Witkop, CJ Jr, Quevedo WC Jr, Fitzpatrick TB, and King RA: Albinism, in Scriver CR, Begudet AL, Sly WS and Valla D: The Metabolic Basis of Inherited Disease, ed 6. New York, McGraw Hill, 1989, p 2905-2947.
There are numerous theories regarding what causes Parkinson’s disease, such as Lewy bodies; these are proteins that are abnormal and aged, accumulated together. Another theory is pointing towards oxidative stress; this is when there is a loss of ability with the Dopaminergic neurons in processing excess amounts of toxic free radicals, leading to their death. Mitochondrial dysfunction and inflammation in ...
U.S. National Library of Medicine, 26 Sept. 2011. Web. The Web. The Web. 19 Nov. 2013.
... Medicine. 3rd ed. Vol.3. Detroit: Gale, 2006.2139-2141. Gale Virtual Reference Library. Web. 3 Apr. 2014.
...apter 362. Glycogen Storage Diseases and Other Inherited Disorders of Carbohydrate Metabolism. In D.L. Longo, A.S. Fauci, D.L. Kasper, S.L. Hauser, J.L. Jameson, J. Loscalzo (Eds), Harrison's Principles of Internal Medicine, 18e. Retrieved January 21, 2012 from http://www.accessmedicine.com/content.aspx?aID=9144477.
Ed. David Zieve. U.S. National Library of Medicine, 26 Feb. 2014. Web. The Web.